Skip to Content

Spiriva FDA Approval History

FDA Approved: Yes (First approved January 30, 2004)
Brand name: Spiriva
Generic name: tiotropium bromide
Dosage form: Inhalation Powder
Company: Boehringer Ingelheim
Treatment for: COPD, Maintenance

Spiriva HandiHaler (tiotropium bromide) is an anticholinergic indicated for the long-term, once-daily, maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), and for reducing COPD exacerbations.

Development Timeline for Spiriva

DateArticle
Dec 18, 2009ApprovalFDA Approves Spiriva HandiHaler for the Reduction of COPD Exacerbations
Jan 30, 2004ApprovalSpiriva HandiHaler Boehringer Ingelheim - Treatment for Chronic Obstructive Pulmonary Disease (COPD)

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.